Easterly Investment Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41,942
| Closed | -$9.04M | – | 201 |
|
|
2024
Q1 | $9.04M | Buy |
41,942
+36,858
| +725% | +$7.95M | 0.69% | 57 |
|
|
2023
Q4 | $1.32M | Sell |
5,084
-1,778
| -26% | -$460K | 0.14% | 126 |
|
|
2023
Q3 | $1.76M | Sell |
6,862
-27
| -0.4% | -$6.94K | 0.19% | 106 |
|
|
2023
Q2 | $1.96M | Hold |
6,889
| – | – | 0.17% | 108 |
|
|
2023
Q1 | $1.92M | Buy |
6,889
+96
| +1% | +$26.7K | 0.17% | 110 |
|
|
2022
Q4 | $1.88M | Buy |
6,793
+1,995
| +42% | +$552K | 0.16% | 112 |
|
|
2022
Q3 | $1.28M | Sell |
4,798
-1,334
| -22% | -$356K | 0.12% | 123 |
|
|
2022
Q2 | $1.25M | Sell |
6,132
-8,728
| -59% | -$1.78M | 0.11% | 126 |
|
|
2022
Q1 | $3.13M | Sell |
14,860
-15,635
| -51% | -$3.29M | 0.24% | 86 |
|
|
2021
Q4 | $7.32M | Sell |
30,495
-976
| -3% | -$234K | 0.53% | 70 |
|
|
2021
Q3 | $8.91M | Buy |
+31,471
| New | +$8.91M | 0.6% | 60 |
|